摘要
目的:探讨果胶铋联合赛庚啶及柳氮磺吡啶治疗溃疡性结肠炎的临床效果。方法:选取2012年1月-2013年1月收治入院的溃疡性结肠炎患者180例,按随机数字表法分为对照组和治疗组,各90例。对照组采用口服柳氮磺胺吡啶片联合地塞米松治疗。治疗组采用果胶铋联合赛庚啶及柳氮磺吡啶治疗。观察两组患者临床效果。结果:治疗组总有效率98.89%,较对照组总有效率明显提高20.00%。结论:经临床研究结果可见,采用果胶铋联合赛庚啶及柳氮磺吡啶治疗溃疡性结肠炎在临床治疗中取得较好的效果。
Objective：To explore the clinical effect of colloidal bismuth pectin combined with cyproheptadine and sulfasalazine in the treatment of ulcerative colitis.Method：A total of 180 cases with ulcerative colitis received in our hospital from January 2012 to January 2013 were collected,and they were divided into the control group and the treatment group by the random number table,each group had 90 cases.Patients in the control group were treated with oral sulfasalazine tablets combined with dexamethasone in treatment.Patients in the treatment group were treated with colloidal bismuth pectin combined with cyproheptadine and sulfasalazine.The clinical effects of the two groups were observed.Result：The total effective rate in the treatment group was 98.89%,and it increased 20.00%compared with that in the control group.Conclusion：Colloidal bismuth pectin combined with cyproheptadine and sulfasalazine in the treatment of ulcerative colitis have better clinical effect in the clinical treatment according to the clinical results of this study.
出处
《中外医学研究》
2014年第5期22-23,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
果胶铋
赛庚啶
柳氮磺吡啶
溃疡性结肠炎
Colloidal bismuth pectin
Cyproheptadine
Sulfasalazine
Ulcerative colitis
